Hold Rating on Marinus Pharmaceuticals Amid Strategic Uncertainty and TRUST-TSC Study Setbacks
JMP Securities analyst Jason Butler has reiterated their neutral stance on MRNS stock, giving a Hold rating today. Jason Butler’s rating ...